Cargando…
Ferroptosis-Specific Inhibitor Ferrostatin-1 Relieves H(2)O(2)-Induced Redox Imbalance in Primary Cardiomyocytes through the Nrf2/ARE Pathway
OBJECTIVE: Ischemic heart disease (IHD) has always been the focus of attention of many researchers in cardiovascular disease, and its pathogenesis is also very complicated. Ferroptosis may be involved in the occurrence and development of IHD. METHODS: First, primary cardiomyocytes were treated with...
Autores principales: | Sun, Chaofeng, Peng, Fang, Li, Jianfei, Cui, Xudong, Qiao, Xin, Zhu, Wangliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888041/ https://www.ncbi.nlm.nih.gov/pubmed/35242242 http://dx.doi.org/10.1155/2022/4539932 |
Ejemplares similares
-
Insight into the mechanism of ferroptosis inhibition by ferrostatin-1
por: Miotto, Giovanni, et al.
Publicado: (2019) -
Ferrostatin-1 alleviates cytotoxicity of cobalt nanoparticles by inhibiting ferroptosis
por: Zhang, Weinan, et al.
Publicado: (2022) -
Treatment with the Ferroptosis Inhibitor Ferrostatin-1 Attenuates Noise-Induced Hearing Loss by Suppressing Ferroptosis and Apoptosis
por: Ma, Peng-Wei, et al.
Publicado: (2022) -
Ferroptosis: Redox Imbalance and Hematological Tumorigenesis
por: Lan, Hongying, et al.
Publicado: (2022) -
Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis
por: Liu, Pengfei, et al.
Publicado: (2020)